Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 1,972.00
-38.20 (-1.90%)
Sep 30, 2025, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 149.60 billion as of September 30, 2025. Its market cap has decreased by -0.08% in one year.
Market Cap
149.60B
Enterprise Value
141.73B
Revenue
19.89B
Ranking
n/a
PE Ratio
26.47
Stock Price
1,972.00
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 149.60B, an increase of 2,671,848.91%. That is a compound annual growth rate of 54.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 149.60B | -21.31% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | 38.35B | 68.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.02B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,211.15B |
| Apollo Hospitals Enterprise | 1,079.82B |
| Mankind Pharma | 1,024.84B |
| Zydus Lifesciences | 981.08B |
| Fortis Healthcare | 704.19B |
| Alkem Laboratories | 649.60B |